Relationship of Circulating Growth and Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry With Age and Skeletal Muscle Strength in Healthy Adults
- PMID: 30380014
- PMCID: PMC6298188
- DOI: 10.1093/gerona/gly255
Relationship of Circulating Growth and Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry With Age and Skeletal Muscle Strength in Healthy Adults
Abstract
Background: Growth and differentiation factors 8 (GDF8) and 11 (GDF11) have attracted attention as targets for rejuvenating interventions. The biological activity of these proteins may be affected by circulating antagonists such as their respective prodomains, follistatin (FST315), WFIKKN1, and WFIKKN2. Reports of the relationship of GDF8 and GDF11 and their antagonists with aging and aging phenotypes such as skeletal muscle strength have been conflicting possibly because of difficulties in measuring these proteins and polypeptides.
Methods: Plasma GDF8 and GDF11 and their antagonists were measured using a multiplexed selected reaction monitoring assay and liquid chromatography-tandem mass spectrometry in 160 healthy adults aged 22-93 years. Quadriceps strength was measured by knee extensor torque using isokinetic dynamometry.
Results: Spearman correlations with age were the following: GDF11 prodomain (r = .30, p = .001), GDF11 mature protein (r = .23, p = .004), FST315 (r = .32, p < .0001), WFIKKN1 (r = -.21, p = 0.008), and WFIKKN2 (r = .18, p = .02). Independent of age, FST315 and WFIKKN1 were negatively associated with knee strength (p = .02, p = .03, respectively) in a multivariable model that included both GDF8 and GDF11 mature proteins.
Conclusions: When measured by an antibody-free selected reaction monitoring assay, GDF8, GDF11, and their antagonists are found in the circulation in the ng/mL range. In healthy adults, plasma GDF11 and antagonists FST315, WFIKKN1, and WFIKKN2 differed by age. Antagonists of GDF8 and GDF11, but not GDF8 and GDF11, were independently associated with skeletal muscle strength. Further work is needed to characterize the relationship of these protein and polypeptides with sarcopenia-related phenotypes such as physical function and walking disability.
Figures


Similar articles
-
Relationships of GDF8 and 11 and Their Antagonists With Decline of Grip Strength Among Older Adults in the Baltimore Longitudinal Study of Aging.J Gerontol A Biol Sci Med Sci. 2023 Oct 9;78(10):1793-1798. doi: 10.1093/gerona/glad135. J Gerontol A Biol Sci Med Sci. 2023. PMID: 37235639 Free PMC article.
-
A targeted proteomic assay for the measurement of plasma proteoforms related to human aging phenotypes.Proteomics. 2017 Aug;17(15-16):10.1002/pmic.201600232. doi: 10.1002/pmic.201600232. Proteomics. 2017. PMID: 28508553 Free PMC article.
-
Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men.BMC Geriatr. 2018 Aug 30;18(1):200. doi: 10.1186/s12877-018-0888-y. BMC Geriatr. 2018. PMID: 30165829 Free PMC article.
-
The role of GDF11 in aging and skeletal muscle, cardiac and bone homeostasis.Crit Rev Biochem Mol Biol. 2019 Apr;54(2):174-183. doi: 10.1080/10409238.2019.1610722. Crit Rev Biochem Mol Biol. 2019. PMID: 31144559 Review.
-
Biological functions of the WAP domain-containing multidomain proteins WFIKKN1 and WFIKKN2.Biochem Soc Trans. 2011 Oct;39(5):1416-20. doi: 10.1042/BST0391416. Biochem Soc Trans. 2011. PMID: 21936825 Review.
Cited by
-
Characterization of Circulating Protein Profiles in Individuals with Prader-Willi Syndrome and Individuals with Non-Syndromic Obesity.J Clin Med. 2024 Sep 25;13(19):5697. doi: 10.3390/jcm13195697. J Clin Med. 2024. PMID: 39407757 Free PMC article.
-
Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes.Aging (Albany NY). 2019 Mar 21;11(6):1733-1744. doi: 10.18632/aging.101865. Aging (Albany NY). 2019. PMID: 30897065 Free PMC article.
-
Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functions.Mol Cell Biochem. 2025 Mar;480(3):1535-1553. doi: 10.1007/s11010-024-05120-y. Epub 2024 Sep 28. Mol Cell Biochem. 2025. PMID: 39340593 Free PMC article. Review.
-
Circulating Growth Differentiation Factors 11 and 8, Their Antagonists Follistatin and Follistatin-Like-3, and Risk of Heart Failure in Elders.J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1):glad206. doi: 10.1093/gerona/glad206. J Gerontol A Biol Sci Med Sci. 2024. PMID: 37624693 Free PMC article.
-
Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice.J Transl Med. 2019 Dec 17;17(1):422. doi: 10.1186/s12967-019-02166-1. J Transl Med. 2019. PMID: 31847906 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous